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Although apparently phenotypically normal at birth, mice heterozygous for inactivation of the gene encoding parathyroid
hormone-related peptide (PTHrP) develop haplotype insuf®ciency by 3 months of age. In addition to histologic and morpho-
logic abnormalities similar to those seen in homozygous mutants, heterozygous animals demonstrated alterations in
trabecular bone and bone marrow. These included metaphyseal bone spicules which were diminished in volume, irregularly
distributed, and less well developed than those seen in age-matched controls as well as bone marrow, which contained an
inordinate number of adipocytes. A substantial reduction in PTHrP mRNA was detected in heterozygous tissue, while
circulating parathyroid hormone (PTH) and calcium concentrations were normal. Thus, while a physiologic concentration
of PTH was capable of maintaining calcium homeostasis, it was incapable of compensating for PTHrP haploinsuf®ciency
in developing bone. In normal animals, both PTHrP and the PTH/PTHrP receptor were expressed predominantly in chondro-
cytes situated throughout the proliferative zone of the tibial growth plate. In the metaphysis, the PTH/PTHrP receptor
was identi®ed on osteoblasts and preosteoblastic cells situated in the bone marrow, while PTHrP was expressed only by
osteoblasts. These observations indicate that postnatal bone development involves susceptible pathways that display
exquisite sensitivity to critical levels of PTHrP and imply that the skeletal effects of PTH are in¯uenced by locally produced
PTHrP. Moreover, identi®cation of both the ligand and its N-terminal receptor in metaphyseal osteoblasts and their
progenitors suggests an autocrine/paracrine role for the protein in osteoblast differentiation and/or function. Impairment
in this function as a consequence of PTHrP haploinsuf®ciency may critically in¯uence the course of bone formation,
resulting in altered trabecular architecture and perhaps low bone mass and increased bone fragility. q 1996 Academic Press, Inc.
INTRODUCTION Suva et al., 1987). The sequences of cDNAs and genes en-
coding this peptide have been determined (Mangin et al.,
Parathyroid hormone-related peptide (PTHrP)1 is an onco- 1988; Yasuda et al., 1989a,b; Karaplis et al., 1990). The ho-
protein involved in the pathogenesis of malignancy-associ- mology in the NH2-terminal region of parathyroid hormone
ated hypercalcemia (Strewler et al., 1987; Burtis et al., 1987; (PTH) and PTHrP facilitates their interaction at a common
target tissue receptor (JuÈ ppner et al., 1991; Abou-Samra et
al., 1992) and results in similar activities with respect to1 Abbreviations used: PTHrP, parathyroid hormone-related pep-
bone metabolism and systemic calcium homeostasis (Ro-tide; PTH, parathyroid hormone; RT-PCR, reverse transcriptase±
dan et al., 1983; Horiuchi et al., 1987; Kemp et al., 1987;polymerase chain reaction; SEM, scanning electron microscopy;
Rabbani et al., 1988; Thompson et al., 1988) Unlike PTH,TEM, transmission electron microscopy; ALPase, alkaline phos-
phatase; PT cell, parathyroid hormone target cell. whose expression is localized to parathyroid cells, PTHrP
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perScript II RNase H-reverse transcriptase (Gibco BRL, Gaithers-is produced in various normal cells and tissues, including
burg, MD).keratinocytes, heart, smooth muscle, many endocrine cells,
Quantitative PCR was then applied to precisely determine theand lactating mammary glands (Merendino et al., 1986;
amount of glyceraldehyde-6-phosphate dehydrogenase (GAPDH)Thiede and Rodan, 1988; Thiede et al., 1990; Drucker et
transcripts in each sample as described previously (Lipman et al.,al., 1989; Kramer et al., 1991; Deftos et al., 1993). In parallel
1994). Subsequently, PCR was performed to amplify PTHrP tran-
with the broad distribution of PTHrP, the PTH/PTHrP re- scripts using the dilutions of normal (cDNA/competitive template
ceptor has been reported to be widespread in various tissues (c.t.) of 1.0) and heterozygote cDNA (cDNA/c.t. of 1.0) that had
(UrenÄa et al., 1993), despite the fact that it had previously been shown by densitometric scanning to contain equal amounts
been considered to be localized only to the classical PTH of GAPDH transcripts. Sense (OC1: 5*-GCT GTG TCT GAA CAT
CAG CTA CT-3* ) and antisense (OC2: 5*-GAT CCC AAT GCAtarget tissues of bone and kidney. This widespread distribu-
TTT ACA GTA TG-3 * ) primers were used to amplify the endoge-tion of ligand and receptor suggests that PTHrP may act in
nous 531-bp PTHrP fragment. The thermal cycling parameters con-an autocrine and/or paracrine mode (Goltzman et al., 1989;
sisted of denaturing at 947C for 1 min, annealing at 547C for 1Orloff et al., 1989). Evidence to support such a mechanism
min, and extension at 727C for 1 min for 35 cycles. Ten-microliterof action has been provided by studies with antisense inhibi-
reaction aliquots were electrophoresed on a 2% agarose gel andtion of PTHrP synthesis in vitro (Kaiser et al., 1992, 1994),
visualized by ethidium bromide staining.
by experiments in transgenic mice which overexpress
PTHrP (Wysolmerski et al., 1994; Vasavada et al., 1994),
and by studies of PTHrP gene inactivation in mice via ho-
Determination of Plasma Calcium and Plasma PTHmologous recombination (Karaplis et al., 1994; Amizuka et
Concentrationsal., 1994). All these approaches have provided evidence for
a role for PTHrP in normal cell proliferation and differentia- Plasma was harvested from heparinized blood obtained by cardiac
tion in addition to its role in cancer. puncture from anesthetized wild-type and heterozygous mice. Cal-
A central role for PTHrP in skeletal development has been cium was determined by autoanalyzer (Technicon Laboratories,
New York, NY) and PTH with an immunoradiometric assay thatdemonstrated in mice homozygous for PTHrP gene inacti-
detects both intact PTH (1±84) and N-terminal PTH (1±34) in ro-vation. We have previously examined the dyschondroplastic
dents (Nichols Institute, San Clementi, CA).abnormalities and altered endochondral bone formation in
these animals (Karaplis et al., 1994; Amizuka et al., 1994)
that culminate in their death in the immediate peripartum
Histological and Ultrastructural Analysesperiod. In contrast, heterozygous PTHrP null mice are phe-
notypically normal at birth. Surprisingly, however, these
Wild-type and heterozygous mice were perfused via the left ven-
animals develop dysmorphic features, similar to those ob- tricle with a mixture of 2.5% glutaraldehyde and 2% paraformalde-
served in homozygotes, that became readily apparent by 3 hyde in 0.067 M phosphate buffer (pH 7.4) for 10 min. The femora
months of age. In the present study we examined these mice and tibiae of these mice were then dissected free and maintained
biochemically and morphologically for evidence of a PTHrP in the same solution overnight at 47C. For analysis by scanning
haploinsuf®cient phenotype. electron microscopy (SEM), specimens of long bones were split
and soft tissues eliminated by immersion in hypochlorite prior to
post®xation with 1% OsO4, dehydration, and critical point drying.
Visualization was with a Hitachi S-570 microscope operated at
MATERIALS AND METHODS 20 kV. Specimens for light and transmission electron microscopy
(TEM) were processed as described previously (Warshawsky and
Moore, 1967).Generation of Mice Heterozygous for PTHrP Gene
Inactivation
Mice carrying a null mutation of the PTHrP gene were generated Histomorphometric Analysis
using the technique of homologous recombination (Karaplis et al.,
1994). Wild-type litter mates and fetuses heterozygous for the mu- For histomorphometric analysis, 3-month-old mice heterozygous
tation were identi®ed by Southern blot analysis of genomic DNA (//0) for ablation of the PTHrP gene and wild-type (///) lit-
and used for subsequent analysis. For staining and visualization of termates were injected intraperitoneally with 10 mg/100 g body
skeletons, mice were dissected and stained with alizarin red S, as weight calcein (Wako Pure Chemicals, Osaka, Japan) and sacri®ced
previously described (Karaplis et al., 1994). by cervical dislocation 24 hr later. Tibiae were cleaned and kept
in 70% ethanol for 5 days at 47C, stained according to Villaneuva
(1974; Villanueva and Lundin, 1989) and dehydrated in graded etha-
nol prior to embedding in methyl methacrylate (Wako). Polymer-Reverse Transcriptase±Polymerase Chain Reaction
ized blocks were ground to the midpoint of the longitudinal axis(RT-PCR) for PTHrP
and analyzed using a confocal laser-scanning microscope (LSM-
GB200; Olympus, Tokyo, Japan) and a Hewlett Packard Vecta 396/Kidneys from 3-month-old wild-type (///) and heterozygous
(//0) litter mates were snap-frozen and total RNA was extracted 25 equipped with GB200 3D imaging software. The number (TbN/
mm2) of trabeculae as well as the trabecular volume [BV/TV(%)]from 20 mg of tissue using the RNeasy Total RNA kit (Qiagen,
Chatsworth, CA). For ®rst-strand cDNA synthesis, 5 mg of total was measured in the tibial metaphysis of eight wild-type and seven
heterozygous animals. Statistical analysis was by Student's t test.RNA was primed with oligo(dT) and reverse transcribed using Su-
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A hybridization mixture composed of 50% formamide, 10 mMRadioautographic Studies
Tris±HCl, pH 7.6, 100 mg tRNA, 11 Denhardt's solution, 10%
Chondrocyte proliferation was evaluated in vivo using [3H]- dextran sulfate, 600 mM NaCl, 0.25% SDS, and 1 mM EDTA was
thymidine labeling as described previously (Amizuka et al., 1994). preheated for 10 min at 907C. cRNAs were adjusted to a concentra-
In vivo binding studies using iodinated PTH and PTHrP were per- tion of 0.1±1.0 mg/ml (determined by the protocol of Boehringer
formed as previously reported (Rouleau et al., 1986, 1988, 1990). Mannheim) and denatured by heating at 907C for 2±3 min before
Synthetic [Tyr36] PTHrP (1±36)-NH2 (Peninsula Laboratories, Bel- applying to the sections. After hybridizing overnight at 507C, sec-
mont, CA) and PTH (1±34) (Bachem Corp., Torrance, CA) were tions were washed with 50% formamide in 21 SSC at 50 ±557C for
labeled with 125I to a speci®c activity of 300 mCi/mg using the lacto- 30 min and treated at 377C with a solution of 10 mM Tris±HCl
peroxidase technique (DeMay et al., 1985). 125I-labeled peptides (pH 8.0), 0.5 M NaCl, and 1 mM EDTA (TNE). Non-speci®c binding
were injected either alone (experimental animals) or with a 500- of probes was reduced by RNase A treatment (20 mg/ml in TNE
fold excess of unlabeled hormone (control animals). solution) at 377C for 30 min.
Digoxigenin-labeled sections were preincubated with 2%
blocking agent and incubated for 45 ±60 min with alkaline phospha-
tase-conjugated sheep anti-digoxigenin antibody at a dilution ofImmunocytochemistry for PTHrP, Type II
1:1000. Visualization was achieved using nitroblue tetrazolium saltCollagen, and Chondroitin Sulfate
and 5-bromo-4-chloro-3-indolyl phosphate.
Anesthetized normal mice were perfused with a solution of 2% For double-labeled in situ hybridization, radioactive sense and
paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) for 10 min. antisense cRNA probes for the PTH/PTHrP receptor were prepared
Femora and tibiae were then dissected free and additionally ®xed from the cloned cDNA using [35S]UTP (Amersham Canada, Oak-
in the same solution for 4 hr at 47C. Specimens were decalci®ed ville, ON). Digoxigenin-labeled probes, prepared as described above,
in 10% EDTA for 1 week, embedded in OCT compound, and frozen were used for PTHrP. After reduction of the average probe length
by immersion in liquid nitrogen. Cryostat sections (10 mm thick) to 300 bases, radioactive antisense probes (5±10 1 104 cpm/ml)
were collected on poly-L-lysine-coated glass slides (Polyscience and digoxigenin-labeled probes were added together in the same
Inc., Warrington, PA) and then treated with a mixture of 95% meth- hybridization mixture. Sections were then incubated with the hy-
anol and 0.3% H2O2 for 30 min to inhibit endogenous peroxidase. bridization mixture as described above. Immunodetection of digox-
PTHrP immunocytochemistry was performed as described pre- igenin-labeled probes was performed, as described above, prior to
viously (Amizuka et al., 1994) using polyclonal antisera raised detection of radioactivity by radioautography. For radioautography,
against synthetic PTHrP (1±34) (17, 36) or PTHrP (87±110). Type sections were dipped in Kodak NTB-2 liquid emulsion and exposed
II collagen and chondroitin sulfate immunocytochemistry were for 2 weeks in the dark at 47C. Sense probes were used as controls.
performed on longitudinal frozen sections of femora and tibiae of
wild-type and heterozygous littermates as previously described
(Amizuka et al., 1994). RESULTS
Gross Morphology and Molecular and BiochemicalIn Situ Hybridization of PTHrP, PTH/PTHrP
Characteristics of Heterozygous MiceReceptor, and Alkaline Phosphatase (ALPase)
Mice with only one functional allele for PTHrP displayedFor in situ hybridization to localize mRNAs encoding PTHrP,
no obvious abnormalities until 3 months postpartum, atPTH/PTHrP receptor, and ALPase, femora and tibiae were har-
which time they developed short, blunt snouts relative tovested from wild-type mice and Sprague±Dawley rats as described
and embedded in paraf®n after decalci®cation. Paraf®n sections (4± their wild-type litter mates. Undecalci®ed preparations of
6 mm thick) on poly-L-lysine-coated glass slides were deparaf®nized the heads of these animals, stained with alizarin red, re-
and rehydrated in decreasing concentrations of ethanol prior to vealed incisal malocclusion due to reduced protrusion of
rinsing with PBS. Sections were treated with 4% paraformaldehyde the maxilla. We therefore examined the possibility that the
in 0.1 M phosphate buffer for 15 min, with proteinase K (10 mg/ml) heterozygous animals were displaying a PTHrP haploinsuf-
in 10 mM Tris±HCl (pH 8.0) at 377C for 15 min, and then with ®cient phenotype; i.e., two copies of the gene are required
0.2 M HCl for 10 min. Acetylation was achieved by incubating for
for a normal phenotype.10 min with 0.25% acetic anhydride in 0.1 M triethanolamine
Using RT-PCR, we ®rst compared the relative amounts(pH 8.0).
of PTHrP mRNA transcripts in kidney tissue removed fromSense and antisense cRNA probes for PTHrP were obtained re-
3-month-old wild-type and heterozygous littermates. Thespectively by transcription of a 620-bp fragment of rat PTHrP
cDNA and a 537-bp fragment of the hPTHrP gene (Kaiser et al., cDNAs to be compared were standardized to contain equal
1992) using digoxigenin-labeled UTP (Boehringer Mannheim, quantities of GAPDH RT-cDNA. This was accomplished
Mannheim, Germany). Sense and antisense cRNA probes for the by coampli®cation of a constant amount of GAPDH com-
PTH/PTHrP receptor were obtained from cDNA (kindly provided petitive template and serially diluted cDNAs (Fig. 1A). The
by Dr. Abdul Abou-Samra, Massachusetts General Hospital, Bos- dilutions of normal and heterozygote cDNA that gave equal
ton, MA) employing T7 and SP6 RNA polymerase, respectively. band intensities (determined by scanning densitometry)
Antisense cRNA for ALPase was prepared from a 2.5-kb fragment,
were subsequently used to amplify PTHrP cDNA. As shownrAP54 (kindly provided by Dr. Gideon A. Rodan, Merck, Sharp and
in Fig. 2B, the PTHrP transcript level was much reduced inDohme Laboratories, West Point, PA), inserted into the EcoRI site
the heterozygote kidney compared to that of the wild-typeof pBS(/) (Stratagene, La Jolla, CA). Probes were reduced in length
tissue, suggesting that gene dosage did indeed exist. In con-to an average of 300 bases, a size appropriate for hybridization in
tissues (Cox et al., 1984). trast to this striking reduction in the level of tissue PTHrP
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bones of these animals histologically for further evidence
of haploinsuf®ciency. Using SEM, the three-dimensional
structure of the femur of a 3-month-old heterozygote (Fig.
2B) was compared with that of its wild-type littermate (Fig.
2A). Although the overall size of the distal portion of these
bones was similar, the epiphyseal head was smaller and the
epiphyseal cartilage reduced in size in the heterozygotes. In
the metaphysis of the wild-type mouse, bone spicules were
of uniform size and extended parallel to the longitudinal
axis, whereas those of the heterozygote were not oriented
longitudinally and were of variable thickness and length.
These alterations were prominent in 3-month-old heterozy-
gotes but of minor consequence in 1.5-month-old mice.
There were no apparent abnormalities in cortical bone at
either time point.
Longitudinal histological sections (Figs. 2C and 2D) of
tibiae and femora from heterozygous mice revealed fewer
mixed spicules, which also had an abnormal orientation,
in metaphyseal bone. In addition, an inordinate number of
adipocytes were observed in the bone marrow of these 3-
month-old mice compared with that in their wild-type litter
mates (compare Figs. 2C and 2D). Nonmarrow cells in the
intertrabecular regions occasionally also contained lipid
droplets. At 1.5 months there were fewer adipocytes in the
marrow and lipid droplets were not seen in nonmarrow cells
in this region.
In the growth plate of the heterozygotes, clusters of chon-
drocytes disrupting the orderly columns were often ob-
served (compare Figs. 2E and 2F), resulting in distortion of
the longitudinal cartilage partitions. This local failure of
chondrocytes to assemble the correct cartilage matrix archi-FIG. 1. Comparative analysis of PTHrP mRNA transcripts in 3-
tecture most probably accounts for the abnormal distribu-month-old animals by RT-PCR. (A) One nanogram of GAPDH com-
tion and size of mixed spicules observed under SEM in thepetitive template (c.t.) was coampli®ed with serial twofold dilu-
metaphyseal bone tissue of the heterozygotes.tions of reverse-transcribed cDNA derived from wild-type (///) or
In keeping with the abnormalities seen in homozygousheterozygous (//0) kidneys. The top band represents the cDNA
ampli®cation product (arrow), while the bottom band is derived mutants, chondrocytes of 3-month-old heterozygotes con-
from ampli®cation of the c.t. (arrowhead). (Bottom) The results of tained numerous dispersed glycogen granules throughout
densitometric scanning of the respective bands are shown. (B) their cytoplasm and [3H]thymidine incorporation was
cDNA calibrated to contain identical GAPDH transcript equiva- slightly but signi®cantly decreased (3.03 { 0.09% versus
lents (giving a ratio 1.0 cDNA/c.t. in both cases) was used to am- 3.38 { 0.09%; mean { SEM of six determinations in two
plify PTHrP transcripts. The band intensity of the ampli®cation
experiments, P 0.05). In contrast, their capacity to expressproduct from the heterozygous kidney compared to that from the
matrix-associated proteins appeared to be unaltered. Immu-wild-type kidney provided a ratio of 0.3. Control, no cDNA added.
nostaining for type II collagen and chondroitin sulfateThe molecular weight marker is a fX174DNA±HaeIII digest.
showed similar patterns of distribution in normal and het-
erozygous animals, as did in situ hybridization for ALPase
mRNA (data not shown).
As shown in Fig. 3, histomorphometric analysis of thetranscripts, heterozygous mice displayed normal concentra-
tions of plasma calcium (1.94 { 0.09 mM; normal, 1.97 { proximal tibial metaphysis of wild-type (///) and heterozy-
gous (//0) mice revealed a signi®cant reduction in trabecu-0.11 mM; each value is the mean { SEM of six determina-
tions) and of plasma PTH (33.7 { 13.9 pg/ml; normal, 37.9 lar bone volume although the numbers of trabeculae were
not signi®cantly different.{ 11.1 pg/ml; each value is the mean { SEM of six determi-
nations).
Localization of PTHrP and the PTH/PTHrP
ReceptorHistological Alterations of Long Bones in
Heterozygous Mice In light of our observations documenting the existence of
a haploinsuf®cient phenotype in heterozygous PTHrP mu-Given the dysmorphic features and reduced level of
PTHrP mRNA in the heterozygotes, we examined the long tants and to assess the role played by PTHrP in their skeletal
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localization studies were similar in both groups of animals,
only the results from normal animals have been shown.
Both PTHrP mRNA (Fig. 4A) and protein (Fig. 4B) were
expressed most intensely by plump osteoblasts on mixed
spicules close to the epiphyseal plate. Flattened osteoblasts
(bone lining cells) in the epiphysis and diaphysis demon-
strated weaker reactivity, as did some super®cial osteo-
cytes. Osteoclasts revealed neither gene expression nor im-
munoreactivity for PTHrP. No reactivity was evident in
sections treated with a sense probe for in situ hybridization
(Fig. 4C) or with preadsorbed serum for immunocytochem-
istry (Fig. 4D).
PTH/PTHrP receptor gene expression was distributed
mainly in the proliferative zone of the epiphyseal growth
plate, including the uppermost region of the hypertrophic
zone, but not in the lower hypertrophic zone (Fig. 5A). In
bone tissue, mature osteoblasts on the bone surface and
nonmarrow ``preosteoblastic'' cells (previously called PT
cells by us) located in the intertrabecular region expressed
mRNA encoding the PTH/PTHrP receptor (Fig. 5B). PT cells
are characterized by having minimal rough endoplasmic re-
ticulum, many vesicles, abundant glycogen granules, and
scattered Golgi apparatus (Rouleau et al., 1988, 1990). A
similar distribution of binding of both 125I-labeled PTHrP
and 125I-labeled PTH to both mature osteoblasts and PT cells
was observed by light microscope radioautography after in
vivo injection (Fig. 5C). Using electron microscope radioau-
tography, iodinated ligand was found to bind to the surface
of both chondrocytic and osteoblastic cell types.
Double-labeled in situ hybridization for PTHrP and its
FIG. 3. Confocal laser microscopy of the tibial metaphysis of 3- receptor con®rmed that PTHrP mRNA is expressed in the
month-old wild-type (///) and heterozygous (//0) mice demon- metaphysis mainly in osteoblasts (Fig. 6A), whereas mRNA
strating bone formation surfaces represented by calcein (white) la- encoding the PTH/PTHrP receptor is expressed in both os-
beling. In wild-type tibiae (A), trabeculae are well formed and run teoblasts and nonmarrow cells between the spicules (Figs.
continuously parallel to the longitudinal axis of the bone while
6A and 6B).those of heterozygous mice (B) form disorganized clusters with no
apparent longitudinal alignment. Less calcein deposition is seen
in the heterozygous bone. (C) The results of histomorphometric
analysis of the tibial metaphysis of wild-type (///) and heterozy- DISCUSSION
gous (//0) animals. Bars represent the mean{SD of measurements
for eight wild-type and seven heterozygotes for trabecular bone area
Our studies have demonstrated that mice heterozygousexpressed as a percentage of total metaphyseal area [BV/TV (%)]
for targeted ablation of the PTHrP gene demonstrate(right) and for number of trabeculae/mm2 of metaphyseal area
haploinsuf®ciency, that is, a single copy of the PTHrP gene[Tb.N/mm2] (left).
is inadequate for the development of a normal phenotype.
Morphologically, the defects in heterozygotes appear some-
what similar to those seen in mice homozygous for PTHrPabnormalities, we examined the distribution of both the
ligand and its receptor in bone tissue from normal (///) gene ablation (Amizuka et al., 1994), although the alter-
ations in trabecular bone structure and the in®ltration ofand heterozygous (//0) animals. As the results from these
FIG. 2. (A and B) Scanning electron micrographs of femora from normal (A) and heterozygous (B) littermates. The overall sizes of these
femora are similar. However, in the metaphysis of the normal femur mixed spicules are aligned in parallel along the longitudinal axis,
whereas in the metaphysis of heterozygotes, mixed spicules are irregularly distributed and not oriented longitudinally. (C±F) Longitudinal
sections of tibiae from normal (C, E) and heterozygous (D, F) littermates. Mixed spicules in the tibia of the heterozygote (D) are less well
developed compared to those of normal mice (C). Numerous adipocytes (arrows) can be seen in the bone marrow of the heterozygote. In
the epiphyseal growth plate of the normal tibia (E), chondrocyte columns extend parallel to the longitudinal axis, whereas in the heterozy-
gotes (F) clusters of chondrocytes (arrowheads) are seen distorting the intercolumnar septa. Pro, proliferative zone. Bar, (A, B) 0.5 mm; (C,
D) 100 mm; and (E, F) 20 mm.
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FIG. 4. Localization of PTHrP by in situ hybridization (A) and by immunocytochemistry (B) in the metaphyseal bone tissue. (A) Using an
antisense riboprobe, hybridization signals of PTHrP (brown color) are observed mainly in osteoblasts (OB) on the mixed spicules (ms) of the
normal metaphysis. (B) PTHrP immunoreactivity (light brown color) is also seen mainly in osteoblasts (OB). However, a faint reaction can also
be detected in some osteocytes (arrowheads) in the super®cial layer of the bone matrix. No signals were observed using a sense riboprobe (C)
or if the antiserum was preadsorbed with 100 mg/ml of PTHrP-(1-34) (D). All sections are counterstained with methyl green. All bars, 20 mm.
FIG. 5. PTH/PTHrP receptor mRNA detected by in situ hybridization and protein detected by binding of radioligand. (A) Hybridization
signals for the PTH/PTHrP receptor (brown color, arrows) are detected mainly in chondrocytes of the proliferative zone (Pro) but not in
the hypertrophic zone (Hyp) of the epiphyseal plate. In the tibial metaphysis (B) osteoblasts (OB, double arrows) as well as preosteoblastic
PT cells (PT) express mRNA encoding PTH/PTHrP receptor. (C) Light microscope radioautograph demonstrating 125I-labeled PTHrP binding
in the tibial metaphysis. Silver grains representing hormone binding are localized to differentiated osteoblasts (double arrows) and to PT
cells and their processes (PT) seen in the intertrabecular spaces between the mixed spicules (ms). All bars, 20 mm.
FIG. 6. Double-labeled in situ hybridization of PTHrP and the PTH/PTHrP receptor in metaphyseal bone. (A) PTHrP mRNA (brown
color) expressed mainly in osteoblasts (OB) located on mixed spicules, whereas mRNA encoding the PTH/PTHrP receptor (indicated by
®ne black silver grains) is found both on osteoblasts and nonmarrow cells including preosteoblasts (arrows). A higher magni®cation of A
is provided in B. Sections are counterstained with methyl green. Bar in A, 10 mm, and in B, 5 mm.
172
173
174 Amizuka et al.
the bone marrow and intertrabecular spaces by adipocytes of the hormone and perhaps the pulsatile nature of its secre-
tion. Our studies and those of others (Lee et al., 1993, 1994)are skeletal abnormalities characteristic of the heterozy-
gotes. Furthermore, the defects in homozygous animals oc- now indicate that the capacity of PTH to act in bone must
also be considered in terms of its interaction with receptorscur in the fetus and result in the death of these dyschon-
droplastic mice at birth (Karaplis et al., 1994). In contrast, on osteoblasts which may be occupied to a variable extent
by endogenously produced PTHrP, which itself can act asthe abnormalities in heterozygotes are not evident at birth
and are of minor consequence at 1 and 1/2 months of age. an autoregulatory factor.
Finally, our studies may also bear on the issue of whetherSuch gene dosage effects, appearing at a later stage in the
heterozygotes, could be explained on the basis of decreased PTH and PTHrP exert overlapping or discrete roles in modu-
lating skeletal function. PTH has been reported to be capa-levels of PTHrP in tissues at the precise site and/or at the
precise time it is required (Fisher and Scambler, 1994). It ble of modulating not only osteoblast but also chondrocyte
function (Koike et al., 1990). However, during embryogene-would therefore appear that absolute levels of PTHrP are
critical for normal bone integrity not only in the fetus but sis, PTHrP and its receptor are believed to be expressed at
a much earlier developmental stage than PTH (van de Stolpealso in the postnatal skeleton.
Cellular abnormalities were clearly evident in the epiphy- et al., 1993). Consequently, it is clearly PTHrP de®ciency
per se which is responsible for the marked developmentalseal growth plate of 3-month-old heterozygous mice in
which altered chondrocyte proliferation was observed. De- abnormalities observed in the fetus homozygous for PTHrP
gene ablation. In that model it is dif®cult to determinespite retention of reasonable differentiated function, as indi-
cated by the relatively normal distribution of type II colla- whether PTH could subserve the same functional role in
fetal skeletal development as PTHrP, especially inasmuchgen, chondroitin sulfate, and ALPase, the spatial organiza-
tion of the growth plate was substantially altered. This as recent preliminary studies have suggested that the pheno-
type obtained in animals homozygous for ablation of theappeared to be the primary cause of the distorted and disor-
ganized mixed spicules in the metaphysis of heterozygotes. common PTH/PTHrP receptor (Lanske et al., 1994) is quali-
tatively similar to that occurring in animals homozygousTherefore, it is evident from the current ®ndings that
PTHrP is critically important for normal development of for PTHrP gene ablation. In the present study we have found
that in animals heterozygous for PTHrP gene ablation, phys-the growth plate after birth.
The presence of PTHrP and PTH/PTHrP receptors which iological concentrations of circulating PTH, although capa-
ble of maintaining normal calcium homeostasis, were un-we demonstrated in osteoblastic cells, together with the
abnormalities of trabecular bone which we observed in het- able to compensate for PTHrP haploinsuf®ciency. Conse-
quently, PTHrP appears to play a role distinct from PTHerozygous PTHrP-de®cient animals, indicates that PTHrP
also plays an essential role in osteoblast differentiation and in both growth plate cartilage and trabecular bone in the
postnatal state. One possible explanation for this observa-the subsequent maintenance of normal trabecular architec-
ture. The alterations in trabecular bone and the abundance tion is that a defect in skeletal progenitor cells was caused
by PTHrP de®ciency in utero prior to parathyroid glandof adipocytes in the bone marrow suggest that the PTHrP-
de®cient heterozygote manifests a form of osteopenia. A development and only became manifest in the postnatal
state. A second possibility is that circulating PTH is unabledirect relationship exists between the prevalence of adipo-
cytes in bone marrow tissue and impaired osteogenic cell to permeate and interact with skeletal receptors to which
locally produced PTHrP may bind. This seems unlikely indifferentiation resulting in osteopenia. Such a relationship
has been reported with increasing age and in some patholog- view of the fact that, as determined by radioautography,
circulating PTH and PTHrP can bind to the same receptorical states (osteoporosis) and experimental conditions
(weightlessness, ovariectomy, immobilization) (Meunier et sites in vivo which have now been identi®ed by in situ
hybridization. A third possibility is that domains of theal., 1971; Jee et al., 1983; Wronski et al., 1986; Minaire et al.,
1974). This osteopenia can result not only from defective PTHrP molecule other than those shared with the PTH
molecule may subserve unique functions which are im-function of mature osteoblasts but also from a decrease in
the number of osteoprogenitor cells. Given that the same portant for normal skeletal development. Further studies
are required to test these possibilities.pluripotent stromal stem cells in the bone marrow compart-
ment can give rise to adipocytes and osteoprogenitor cells
(Owen, 1985), the increased number of adipocytes in the
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